NILES, Ohio (MyValleyTributes) – Angelo James, 92 of Niles, passed away at his home Friday evening, October 25, 2024, after a two-month fight to live from a botched gallbladder removal. His liver was ...

Obviously abnormal’ blood test results from Eilis Cronin Walsh not immediately conveyed to medical team, contrary to protocol ...

The practice of discarding gallbladder specimen is standard in most tertiary care hospitals of Pakistan including the primary investigator's own institution on the pretext that "surgeon knows best ...

"They removed content without consulting with me. After working there for twelve years, I was shocked," said Rehak in an interview with the "International Hour" on Kan Reshet Bet. According to ...

The Mahakaleshwar temple administration in Ujjain, Madhya Pradesh, removed an official after a controversy arose over the unauthorized entry of Maharashtra Chief Minister Eknath Shinde’s son ...

Her job involves preserving donated organs for transplantation. She told the outlet that after seeing the patient, she immediately knew something was wrong and he didn’t appear dead.

A Marine Corps veteran was removed from a Delta flight before she ... Over 30,000 active duty personnel and veterans who served in the military after 9/11 have died by suicide – compared to ...

EXCLUSIVE: Crunchyroll‘s next original series will be an anime series adaptation of the Tapas Entertainment-published webcomic The Beginning After the End. Set to drop next year, the series will ...

Oct 18 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Friday it was voluntarily withdrawing its drug, Trodelvy, for patients with a type of bladder cancer after it failed to meet the ...

Gilead Sciences plans to voluntarily withdraw U.S. accelerated approval for Trodelvy in metastatic urothelial cancer. The decision followed results from the TROPiCS-04 study, which failed to meet ...

After falling short in a confirmatory clinical trial, Gilead Sciences has decided to withdraw Trodelvy as a bladder cancer treatment in the U.S. The California biotech announced the decision ...

(Reuters) -Gilead Sciences said on Friday it was voluntarily withdrawing its drug, Trodelvy, for patients with a type of bladder cancer after it failed to meet the main goal in a confirmatory trial.